What is the initial dose of retatrutide in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Dose of Retatrutide

The initial dose of retatrutide is 2 mg subcutaneously once weekly, which serves as the starting dose before escalating to higher maintenance doses of 4 mg, 8 mg, or 12 mg. 1, 2

Dosing Strategy and Escalation

  • Retatrutide requires dose escalation to minimize gastrointestinal side effects, with the 2 mg starting dose used for 4 weeks before increasing to higher maintenance doses. 1, 2

  • The phase 2 obesity trial demonstrated that starting with 2 mg (rather than 4 mg) partially mitigated gastrointestinal adverse events, which were dose-related and mostly mild to moderate in severity. 1

  • For the 4 mg maintenance dose, participants started at 2 mg for the initial period before escalating. 1

  • For the 8 mg maintenance dose, two escalation strategies were tested: starting at either 2 mg or 4 mg, both showing similar efficacy. 1, 2

  • For the 12 mg maintenance dose, the starting dose was 2 mg with gradual escalation over the treatment period. 1, 2

Administration Details

  • Retatrutide is administered as a subcutaneous injection once weekly at any time, regardless of meals. 1, 2

  • The medication is given for extended treatment periods (24-48 weeks in clinical trials) to achieve maximal weight loss and metabolic benefits. 1, 2

Clinical Context

  • In the phase 2 obesity trial, participants had either a BMI ≥30 kg/m² or BMI 27-<30 kg/m² with at least one weight-related condition. 1

  • For type 2 diabetes, participants had HbA1c of 7.0-10.5% and BMI of 25-50 kg/m², with the same 2 mg starting dose strategy. 2

Common Pitfalls to Avoid

  • Do not start at the full maintenance dose (4 mg, 8 mg, or 12 mg) without the initial 2 mg escalation period, as this significantly increases gastrointestinal adverse events including nausea, diarrhea, and vomiting. 1

  • Be aware that retatrutide causes dose-dependent increases in heart rate that peak at 24 weeks (up to 6.7 beats/min increase), which should be monitored during treatment. 1, 3

  • The 1 mg dose showed minimal efficacy compared to placebo and is not recommended as a therapeutic dose. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.